![Lance Thibault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lance Thibault
Direttore Finanziario/CFO presso
FINCH THERAPEUTICS GROUP, INC.
Profilo
Lance E.
Thibault's current job(s) include Managing Director-Accounting & Reporting Advisory at Danforth Advisors LLC since 2020 and Chief Financial Officer at Finch Therapeutics Group, Inc. since 2023.
Mr. Thibault's former job(s) include Director at PricewaterhouseCoopers LLP (United Kingdom), Finance Director at Paratek Pharmaceuticals, Inc., Treasurer at deCODE genetics, Inc. from 2010 to 2010, Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc. from 2016 to 2016, CFO, Secretary & Treasurer at Pieris Pharmaceuticals, Inc. from 2017 to 2018, Chief Financial & Accounting Officer at Arcellx, Inc. in 2022, and Chief Financial Officer at Aadi Subsidiary, Inc. .
Mr. Thibault's education history includes an undergraduate degree from Bentley University in 1988.
Posizioni attive di Lance Thibault
| Società | Posizione | Inizio |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Direttore Finanziario/CFO | 16/05/2023 |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | 01/07/2020 |
Precedenti posizioni note di Lance Thibault
| Società | Posizione | Fine |
|---|---|---|
| ARCELLX, INC. | Direttore Finanziario/CFO | 23/05/2022 |
| WHITEHAWK THERAPEUTICS, INC. | Direttore Finanziario/CFO | 28/11/2021 |
| PIERIS PHARMACEUTICALS | Direttore Finanziario/CFO | 09/08/2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 04/08/2016 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Direttore Finanziario/CFO | 21/05/2010 |
Formazione di Lance Thibault
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax, legal, advisory and consulting services | Commercial Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
